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Highlights 
• Predictive genetic testing of an asymptomatic person has considerable potential to 
predict future risk of COVID-19 severity. 
• Risk alleles for COVID-19 severity due to the pleiotropic effects are associated with 
performance-related traits. 
• Team sport players, power, and combat athletes possess a higher genetic risk for 
COVID-19 severity than untrained subjects or endurance athletes. 
• Polygenic risk scores based on 6 gene polymorphisms show a significant geographical 
variation, putting some countries at greater risk than others. 
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Dear editor, 
As government restrictions put in place to slow the acceleration of the new coronavirus 
disease (COVID-19) pandemic start to ease, many people, including elite athletes, will begin 
to return back to their normal daily activities. Whilst the majority of risk factors for severe 
COVID-19—hypertension, respiratory system disease, obesity, older age, and cardiovascular 
disease1—are exceptionally rare in elite athletes, when athletes train in groups or common 
training areas, they are not immune from contracting the illness; and, whilst the subsequent 
risk of death is low, it is not zero. 
It has been estimated that 22% of the global population are at increased risk of severe 
COVID-19 if infected.2 Precisely because elite athletes are generally young, fit, and healthy, 
the identification of high-risk individuals within this cohort is likely to be difficult, requiring 
a multi-disciplinary approach. One area with potential early promise is that of genetic 
testing,3 with a number of genetic variants tentatively associated with increased susceptibility 
to, and increased chance of complications from, contracting COVID-19.4,5 
So far, 4 studies4,5,6,7 have shown that at least 6 DNA polymorphisms might be 
implicated in COVID-19 severity, with the ABO blood group (ABO) rs657152 A, 
Angiotensin I converting enzyme (ACE) D, Apolipoprotein E (APOE) rs429358 C, Leucine 
zipper transcription factor like 1 (LZTFL1) rs11385942 GA, Transmembrane protein 189-
ubiquitin-conjugating enzyme E2 variant 1 (TMEM189-UBE2V1) rs6020298 A, and 
Transmembrane serine protease 2 (TMPRSS2) rs12329760 C alleles being considered as risk 
factors (Supplementary Table 1). According to the UK Biobank cohort, these risk alleles are 
also associated with immune system disorders (ABO, LZTFL1, TMEM189-UBE2V1), 
thrombosis (ABO), hypertension (ACE, TMPRSS2), dementia (APOE), obesity (ACE, APOE), 
respiratory disorders (ABO, TMPRSS2), and dislipidemia (APOE) (Supplementary Table 1). 
Interestingly, these risk alleles are also associated with performance-related traits 
(Supplementary Table 2), with 4 risk alleles showing favorable effects on endurance and/or 
power.  
It is well-established that genetic and phenotypic variations may have pleiotropic 
effects. For example, a high percentage of type II muscle fibers is positively correlated with 
power performance, but is considered as a risk factor for the development of obesity, diabetes, 
and hypertension,8 which explains why former endurance athletes have lower rates of 
coronary heart disease and obesity compared with power athletes.9 This can be considered a 
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result of natural selection due to the pleiotropic effect of genes, rather than a negative effect 
of power performance on the health of athletes. 
We thus hypothesized that polygenic risk scores for COVID-19 severity based on 6 
DNA polymorphisms may vary across different sporting groups (endurance- and power 
oriented). Using the 1000 Genomes database and our own data of 802 Russian elite athletes 
and 224 controls (Supplementary Table 3 and Methods), we first identified the proportion of 
subjects with increased risk in each population. For this, we classified all subjects according 
to the number of risk alleles they possessed (e.g., carriers of ABO CC, ACE II, APOE TT, 
LZTFL1 GG, TMEM189-UBE2V1 GG, and TMPRSS2 TT genotypes had zero risk alleles, 
and subjects with ABO AA, ACE DD, APOE CC, LZTFL1 GA/GA, TMEM189-UBE2V1 AA, 
and TMPRSS2 CC genotypes had 12 risk alleles). About half of Russian controls (47.3%) 
were carriers of ≥5 risk alleles. This value therefore was considered as a threshold for further 
analysis. 
Long-distance athletes had the lowest proportion of subjects with genotype scores (i.e., 
≥5 alleles) indicative of increased risk (odd ratio (OR)=1.07, p =0.802 compared to controls). 
In comparison, other athletes had a greater proportion of individuals with high risk genotype 
scores. Specifically, middle-distance (OR=1.58, p =0.04), combat (OR=1.63, p =0.048), and 
power (OR=1.74, p =0.0036) athletes, as well as team sport players (OR=1.89, p =0.0005) 
had a significantly higher proportion of subjects with increased genetic risk compared to 
controls (Table 1). Interestingly, the polygenic risk scores show a significant geographical 
variation, putting some countries at greater risk than others (Table 1). 
In conclusion, we identified that team sport, power and combat athletes possess a 
higher genetic risk for COVID-19 severity than untrained subjects or endurance athletes. We 
suggest that genetic testing, alongside more well-established health-related information like 
vitamin D status,10 might be useful to determine the individual risk profiles of each athlete. 
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Table 1  
Proportion of subjects with increased risk for COVID-19 severity. 
Group n 
Proportion of subjects with high 
number of risk alleles (%) 
Russian cohorts   
Russian long-distance athletes 90 48.9 
Russian middle-distance athletes 126 58.7* 
Russian combat athletes 96 59.4* 
Russian power athletes 228 61.0* 
Russian team sport players 262 63.0* 
Russian controls 224 47.3 
Other populations 
Americans (African ancestry) 61 68.9 
Americans (European ancestry) 99 59.6 
Bangladesh  86 59.3 
Barbados  96 82.3 
British  91 53.8 
Chinese  301 28.6 
Colombian  94 54.3 
Finnish  99 60.6 
Gambian  113 80.5 
Indian  205 56.6 
Italian  107 71.0 
Japanese  104 41.3 
Kenyan  99 81.8 
Mexican  64 45.3 
Nigerian  207 82.1 
Pakistan  96 56.3 
Peruvian  85 52.9 
Puerto Rican  104 53.8 
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Sierra Leone  85 89.4 
Spanish  107 59.8 
Sri Lankan  102 51.0 
Vietnamese  99 38.4 
*p <0.05, statistically significant differences between Russian athletes and controls. 
Abbreviation: COVID-19 = new coronavirus disease. 
 
